Option chain shows key data for Bayer's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bayer.

Bayer (OTC:BAYZF) Stock, Option Chain

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Large Cap

News

Health Care

Legal

General

BAYRY

BAYZF

Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company&#39;s stance that product is safe.

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer

Bayer US-Roundup-Ready-to-use-Weed-And-Grass-Killer-Iii-III-Main-5200210-Xxl_0

Media

Pennsylvania judge cuts Bayer&#39;s $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation.

Judge Slashes Bayer&#39;s Massive $2B Roundup Verdict To $400M

Crypto hack Photo by Bits And Splits on Shutterstock

ABBV

ACAD

REGN

Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans&#39; Health Information Stolen In Data Breach In February

Bayer AG

In a report released today, James Quigley from Goldman Sachs maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of €30...

Goldman Sachs Remains a Hold on Bayer (0P6S)

Bayer drops after guidance cut

Bayer Stock: Assessing Upside Potential After Its Q3 Earnings

Bayer Aktiengesellschaft 2024 Q3 - Results - Earnings Call Presentation

Bayer AG (BAYZF) Q3 2024 Earnings Call Transcript

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...

Deutsche Bank  Sticks to Its Hold Rating for Bayer (0P6S)

Bernstein analyst Florent Cespedes maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €30.00. The company's...

Bernstein Keeps Their Hold Rating on Bayer (0P6S)

Barclays analyst Emily Field lowered the firm's price target on Bayer (BAYRY) to EUR 22 from EUR 26 and keeps an Equal Weight rating on the shares....

Bayer price target lowered to EUR 22 from EUR 26 at Barclays

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on November 12 and set a price target of €33.00. ...

Kepler Capital  Remains a Hold on Bayer (0P6S)

Deutsche Bank analyst Falko Friedrichs lowered the firm's price target on Bayer (BAYRY) to EUR 23 from EUR 29 and keeps a Hold rating on the shares...

Comments

Bayer

Bayer (BAYZF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga